ESR1 and breast carcinoma: Based on our included studies, ddPCR technologies are increasingly being used for the detection of ESR1 mutations in advanced breast cancers owing to the enhanced sensitivity of ddPCR, which enables more accurate positive detection of ESR1 mutations in plasma samples.